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Sir,
We read with interest the article by Mounier et al.1 on antibiotic-
impregnated external ventricular drains (AI-EVDs). We consider
that their conclusions are weakened by their choice of methods
15 and a lack of understanding of the intended purpose and mode
of action of the devices.
Regarding their use of the zone-of-inhibition test to determine
antimicrobial activity of removed AI-EVDs, this tests only diffusible
activity from the catheter surface. Their method does not, as is
20 claimed, test the inside surface as only the cut edges are in contact
with the agar. This would be expected to give a larger zone of inhib-
ition than the ‘outer surface’ version (their Figure 1). However, the
legend for their Figure 1 might contain an error: ‘In this example,
“internal diameter” equals 3 mm (no inhibition) and “external
25 diameter” equals 15 mm’. This statement is not borne out in sub-
sequent text: ‘The antimicrobial activity dropped faster for the
external side, with no inhibition. . .’ Also, the zone-of-inhibition test
does not give relevant data as the authors appear to assume that
the AI-EVDs depend on release of antibiotics into the CSF. This
30 is not so: they depend on presenting an antimicrobial surface to
bacteria that alight on it. The diffusible component is not relevant
to their function and is intended to be as small as possible.
The tests for the type of antimicrobial activity are therefore
also not useful. In line with the above paragraph, the AI-EVDs are
35 not designed to release static or cidal concentrations of antimicro-
bials into the CSF, explaining their apparent ‘failure’ to inhibit a
suspension of planktonic bacteria.
When an EVD catheter is removed from a patient, the intracere-
bral part passes through the skin tunnel and it usually becomes
40 contaminated on the external surface. This is why it is important to
sample only the inner surface (by sonication) to determine colon-
ization, yet the authors sampled both surfaces together. This could
explain their ‘colonization’ cases.
The protocol for quantitation of drug content in the AI-EVDs is
45 incorrect. The ‘extraction’ method used cannot be expected to
access drugs in the catheter matrix as a non-polar solvent such
as chloroform or toluene is required for this. Methanol, a polar
solvent, will not penetrate silicone sufficiently to access any drugs
in the matrix and will solubilize only those on the surface.
50The authors say (in their Supplementary Methods) ‘. . .because the
concentration of antibiotics in new EVD was unknown’, yet this in-
formation is in the public domain.
The authors compare their protocols with other published
methods and say that the difference in results is probably
55explained by short periods of exposure in others. They cite here
three studies2–4 (their references 15, 16 and 21) saying that expos-
ure to challenge bacteria was between 5 min and 1 h. Only one
technical paper3 (their reference 16) used a 5 min exposure, but
this was shown to be sufficient to induce consistent colonization
60of control catheters in a constant flow model. The other two2,4
were much more rigorous as though the initial challenges were
1 h, they were followed by further challenges every 2 weeks with
constant flow for 42 days without colonization of AI catheters, but
consistent colonization of controls.
65The authors also refer to three clinical trials of AI-EVDs and say
that, of these, only one was in favour of AI-EVD.5–7 Their reference
3 found in favour, their reference 4 had too few infections in either
group to make it sufficiently powered and, in their reference 5, the
antimicrobial catheters without additional systemic antibiotics
70gave a statistically comparable low infection rate to plain cathe-
ters with long-term systemic antibiotics, but without the cases of
Clostridioides difficile infection reported. It would therefore, in our
view, be misleading to say that there is ‘lack of clinical efficiency’.
There are many misconceptions of the science and mode of
75action of AI-EVDs in this article. This might not be surprising as the
technology is not widely used except in CSF shunts and EVDs.
However, evaluation protocols, test methods and assays and
their rationales are fully described in the literature cited and the
differences in approach taken here explain why the data from
80Mounier et al.1 are so at variance with most other published data
on the topic.
The authors say that they cannot explain the two cases of ven-
triculitis due to Gram-negative bacteria. The Bactiseal formulation
is aimed specifically at Gram-positive bacteria and any cases of
85ventriculitis in patients using this AI-EVD are expected to be due to
Gram-negative bacteria. This same observation has been made
by Ramirez et al.8 and others.
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